VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients

被引:7
|
作者
Englert, F. [1 ]
Bahlke, F. [1 ]
Erhard, N. [1 ]
Krafft, H. [1 ]
Popa, M. -a. [1 ]
Risse, E. [1 ]
Lennerz, C. [1 ]
Lengauer, S. [1 ]
Telishevska, M. [1 ]
Reents, T. [1 ]
Kottmaier, M. [1 ]
Kolb, C. [1 ]
Hessling, G. [1 ]
Deisenhofer, I. [1 ]
Bourier, F. [1 ]
机构
[1] Tech Univ Munich TUM, German Heart Ctr Munich, Dept Electrophysiol, Lazarettstr 36, D-80636 Munich, Germany
关键词
VT ablation; inHEART; Cardiomyopathy; Wall thinning; Late enhancement; VENTRICULAR-TACHYCARDIA; SCAR;
D O I
10.1007/s00392-023-02321-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The eradication of ventricular tachycardia (VT) isthmus sites constitutes the minimal procedural endpoint for VT ablation procedures. Contemporary high-resolution computed tomography (CT) imaging, in combination with computer-assisted analysis and segmentation of CT data, facilitates targeted elimination of VT isthmi. In this context, inHEART offers digitally rendered three-dimensional (3D) cardiac models which allow preoperative planning for VT ablations in ischemic and non-ischemic cardiomyopathies. To date, almost no data have been collected to compare the outcomes of VT ablations utilizing inHEART with those of traditional ablation approaches.Methods The presented data are derived from a retrospective analysis of n = 108 patients, with one cohort undergoing VT ablation aided by late-enhancement CT and subsequent analysis and segmentation by inHEART, while the other cohort received ablation through conventional methods like substrate mapping and activation mapping. The ablations were executed utilizing a 3D mapping system (Carto3), with the mapping generated via the CARTO (R) PENTARAY (TM) NAV catheter and subsequently merged with the inHEART model, if available.Results Results showed more successful outcome of ablations for the inHEART group with lower VT recurrence (27% vs. 42%, p < 0.06). Subsequent analyses revealed that patients with ischemic cardiomyopathies appeared to derive a significant benefit from inHEART-assisted VT ablation procedures, with a higher rate of successful ablation (p = 0.05).Conclusion Our findings indicate that inHEART-guided ablation is associated with reduced VT recurrence compared to conventional procedures. This suggests that employing advanced imaging and computational modeling in VT ablation may be valuable for VT recurrences.
引用
收藏
页码:1478 / 1484
页数:7
相关论文
共 50 条
  • [41] Defects in matrix metalloproteinase inhibitory stoichiometry in patients with non-ischemic or ischemic dilated cardiomyopathy
    Coker, ML
    Zellner, JL
    Crumbley, AJ
    Ding, WC
    Spinale, FG
    CIRCULATION, 1998, 98 (17) : 179 - 180
  • [42] Time course of response to cardiac resynchronization therapy in patients with ischemic and non-ischemic cardiomyopathy
    Marsan, Nina Ajmone
    Van de Veire, Nico R.
    Ypenburg, Claudia
    Bleeker, Gabe B.
    Holman, Eduard R.
    van der Wall, Ernst E.
    Schalij, Martin J.
    Bax, Jeroen J.
    CIRCULATION, 2007, 116 (16) : 545 - 545
  • [43] Electrocardiographic Recognition of Venticular Tachycardia With Successful Endocardial Catheter Ablation in Patients With Non-Ischemic Cardiomyopathy
    Nagase, Satoshi
    Nishii, Nobuhiro
    Hiramatsu, Shigeki
    Murakami, Masato
    Tada, Takeshi
    Tanaka, Masamichi
    Nakagawa, Koji
    Morita, Hiroshi
    Kusano, Kengo
    Ito, Hiroshi
    CIRCULATION, 2009, 120 (18) : S678 - S678
  • [44] Does cardiac resynchronization therapy benefit patients with ischemic and non-ischemic cardiomyopathy similarly?
    Makki, Nader
    Swaminathan, Paari Dominic
    Olshansky, Brian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4378 - 4380
  • [45] Clinical benefit and limitations of CT imaging substrate visualization technology for VT ablation
    Kataoka, Naoya
    Imamura, Teruhiko
    CLINICAL RESEARCH IN CARDIOLOGY, 2025, 114 (04) : 516 - 516
  • [46] Atrioventricular Node Ablation and Biventricular Pacing Improves Heart Failure in Patients With Refractory Atrial Fibrillation and Non-Ischemic but not Ischemic Cardiomyopathy
    Sohinki, Daniel
    Srinivasan, Nishant
    Ho, Jeffrey
    Naseem, Rao
    Joglar, Jose
    Collines, Laura
    Obel, Owen
    CIRCULATION, 2013, 128 (22)
  • [48] Delayed-enhanced magnetic resonance imaging for identifying the ventricular arrhythmia substrate in non-ischemic cardiomyopathy
    Benoit Desjardins
    Fred Morady
    Frank Bogun
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)
  • [49] PREDICTORS OF CARDIAC OUTCOMES BY CMRI IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY
    Elias, Elliott
    Pozo, Eduardo
    Paruchuri, Vijayapraveena
    Gaztanaga, Juan
    Kalman, Jill
    Narula, Jagat
    Fuster, Valentin
    Sanz, Javier
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E612 - E612
  • [50] Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy
    Proietti, Riccardo
    Russo, Vincenzo
    AlTurki, Ahmed
    PHARMACOLOGICAL RESEARCH, 2019, 143 : 27 - 32